MyFinsight
Home
Blog
About
Marketable securities
$331,631K
(9.28%↑ Y/Y)
Cash and cash
equivalents
$106,128K
(-32.04%↓ Y/Y)
Prepaid expenses and
other current assets
$82,752K
(231.79%↑ Y/Y)
Accounts receivable
$7,321K
(-35.51%↓ Y/Y)
Total current assets
$527,832K
(6.43%↑ Y/Y)
Marketable securities -
noncurrent
$190,595K
(11.55%↑ Y/Y)
Operating lease
right-of-use assets
$85,954K
(-33.39%↓ Y/Y)
Investments and other assets
$37,725K
(-52.99%↓ Y/Y)
Property and equipment,
net
$15,058K
(-33.97%↓ Y/Y)
Total assets
$857,164K
(-4.64%↓ Y/Y)
Total liabilities and
stockholders' equity
$857,164K
(-4.64%↓ Y/Y)
Total stockholders
equity
$727,706K
(1.74%↑ Y/Y)
Total liabilities
$129,458K
(-29.50%↓ Y/Y)
Accumulated deficit
-$2,792,959K
(-16.71%↓ Y/Y)
Accumulated other
comprehensive income
-$1,030K
(-257.73%↓ Y/Y)
Additional paid-in capital
$3,521,681K
(13.33%↑ Y/Y)
Total current
liabilities
$79,392K
(-16.87%↓ Y/Y)
Long-term operating lease
liability
$50,066K
(-33.78%↓ Y/Y)
Common stock, 0.0001
par value...
$14K
(40.00%↑ Y/Y)
Accrued expenses
$44,334K
(6.69%↑ Y/Y)
Current portion of
operating lease liability
$23,344K
(-13.51%↓ Y/Y)
Accounts payable
$11,714K
(19.51%↑ Y/Y)
Back
Back
Balance Sheet
Intellia Therapeutics, Inc. (NTLA)
Intellia Therapeutics, Inc. (NTLA)
source: myfinsight.com